http://www.delmarpharma.com
DelMar Pharmaceuticals, Inc. Company Intro
DelMar Pharmaceuticals is developing new cancer therapies in areas where patients are failing or have become intolerable to currently available treatments.
Industry
Healthcare
DelMar Pharmaceuticals, Inc. Headquaters
12707 High Bluff Drive
San Diego,92130
United States
DelMar Pharmaceuticals, Inc. Share price
17 May 2023 13:05 GMT
$0
0.0 (0 %)
DelMar Pharmaceuticals, Inc. Market cap
$
WMC RANKING
2023
DelMar Pharmaceuticals, Inc. # 475
BiotechnologyLatest DelMar Pharmaceuticals, Inc. News
07 Dec 2023
Medical technology co. EndoQuest Robotics closes $42M ...
Houston-based EndoQuest Robotics's $42M Series C-1 investment was led by its legacy investors, CE Ventures Ltd. and McNair Enterprises Ltd. Del Mar, California-...
07 Dec 2023
Medical technology co. EndoQuest Robotics closes $42M ...
Houston-based EndoQuest Robotics's $42M Series C-1 investment was led by its legacy investors, CE Ventures Ltd. and McNair Enterprises Ltd. Del Mar, California-...
07 Dec 2023
Medical technology co. EndoQuest Robotics closes $42M ...
Houston-based EndoQuest Robotics's $42M Series C-1 investment was led by its legacy investors, CE Ventures Ltd. and McNair Enterprises Ltd. Del Mar, California-...
WMC Market Score
WMC Market to Revenue Score
DelMar Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| DelMar Pharmaceuticals, Inc. | USD | $0 | $25,495 | $-30,231 | $ | 475 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total DelMar Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
DelMar Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
DelMar Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
DelMar Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
DelMar Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| DelMar Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
